CN Patent

CN112569208B — 一种盐酸普拉克索药物组合物及其制备方法

Assigned to Sichuan Kelun Pharmaceutical Research Institute Co Ltd · Expires 2023-10-31 · 3y expired

What this patent protects

本发明属于药物制剂技术领域，具体涉及一种盐酸普拉克索口溶膜剂药物组合物及其制备方法。本申请提供的组合物包含高分子成膜材料、增塑剂等。该膜剂不需用水送服，服药方便，口感佳，溶出迅速，非常适合于帕金森患者，尤其是出现咀嚼、吞咽困难、手震颤的患者，大大提高了患者的依从性，本品具有较好的经济效益及社会效益。

USPTO Abstract

本发明属于药物制剂技术领域，具体涉及一种盐酸普拉克索口溶膜剂药物组合物及其制备方法。本申请提供的组合物包含高分子成膜材料、增塑剂等。该膜剂不需用水送服，服药方便，口感佳，溶出迅速，非常适合于帕金森患者，尤其是出现咀嚼、吞咽困难、手震颤的患者，大大提高了患者的依从性，本品具有较好的经济效益及社会效益。

Drugs covered by this patent

Patent Metadata

Patent number
CN112569208B
Jurisdiction
CN
Classification
—
Expires
2023-10-31
Drug substance claim
No
Drug product claim
No
Assignee
Sichuan Kelun Pharmaceutical Research Institute Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.